AARP praises General Assembly for preserving critical health care program

Older adults increasingly feeling the pinch of the recession got a significant break from the Illinois General Assembly, as legislators overrode a partial veto from Gov. Quinn on Thursday, preserving a program aimed at helping Medicare beneficiaries afford prescription drugs.

Last August, Governor Quinn imposed an amendatory veto on legislation (House Bill 366) that updated eligibility for a prescription drug benefit - called Illinois Cares Rx - designed to help Medicare beneficiaries. The veto could have led to the elimination of the entire program.

"The rising costs of health care puts needed prescription drugs out of reach for countless older individuals," said AARP Illinois State Director Bob Gallo. "On behalf of our 1.8 million Illinois members, AARP commends the General Assembly for overriding the veto on this bill, and helping to preserve a critical program for older adults."

Both the House and the Senate took action to override the veto, voting almost unanimously to save the critical health care program. Over 250,000 older Illinoisans will be benefited from the action.

Thursday's override will also allow the state to preserve the property tax relief grants for seniors under the Department on Aging's Circuit Breaker program, which the veto had made subject to appropriations. AARP continues to fight to prevent cuts and reductions to critical programs for older Illinoisans and their families. The Association urges citizens to call the Governor to stop the cuts, by dialing 1-888-616-3322.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanded access to weight-loss drugs could save thousands of lives